Login to Your Account

Thar Pharmaceuticals files for $50M IPO to advance pain therapy

By Peter Winter
BioWorld Insight Editor

Monday, August 22, 2016

Pittsburgh-based Thar Pharmaceuticals Inc. is hoping to follow a similar public trajectory as one of its competitors in the complex regional pain syndrome (CRPS) space, Axsome Therapeutics Inc., which went public late last year raising about $51 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription